Clovis Oncology Inc. (CLVS) fell -5.44% or -1.35 to $23.49. It is close to 898477 shares traded, which is 48.36% compare to the average total volume 1.86 million. The market cap of CLVS is $1.24 billion. The year to date change is 22.67%. The 52 week price range is from $11.5 to $65.24. Price of CLVS have changed -9.61% during last week. It have changed -2.47% over last month, 31.08% over last 3 months, -20.97% over last 6 months and -55.96% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLVS is 25.71. It is 9.45% above current price. The 200-day Moving Averages for CLVS is 30.08. It is 28.05% above current price. The 52-week High is 65.24. It is 177.74% from the current price. The 52-week Low is 11.5. It is -51.04% from current price.
There are some statistics of CLVS. It is has market cap $1.24 billion. The share outstanding is 52.87 million. The average volume is 1.86 million. The percent of top 15 Institution holding is 137.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLVS is -143.16%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLVS is -46.04%.